Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of Antibody Drug Conjugates (ADCs) for cancer patients with unmet needs. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
MRSN Price Trend and Signals
MRSN Option Volumes & Open Interests (aggregated)
MRSN Put Call Ratios and IV (aggregated)
MRSN Financials
2025-10-27Somewhat Bullishprice_signal
Yearly high detected.
2025-10-22Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-16Somewhat Bullishprice_signal
Yearly high detected.
2025-10-15Somewhat Bullishprice_signal
Yearly high detected.
2025-10-14Somewhat Bullishprice_signal
Yearly high detected.
2025-10-13Somewhat Bullishprice_signal
Yearly high detected.
2025-07-18Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-07-18Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-07-18Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.